Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETERNAL-LVO: Tenecteplase vs Standard Care in LVO Stroke
NCT04454788Phase 3Terminated
- Sponsor
- University of Melbourne
- Start
- Aug 2020
- Primary completion
- Jul 2024
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, sponsored by University of Melbourne. Started Aug 2020; status: terminated.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04454788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04454788.